News Room Less than 1 min.Read Banco Comercial Português, S.A. informs about resolutions of the Annual General Meeting Banco Comercial Português, S.A. informs about resolutions of the Annual General Meeting By Investing Today May 23, 2025 FacebookTwitterPinterestWhatsApp Banco Comercial Português, S.A. informs about resolutions of the Annual General Meeting Attachment 2025 05 22 Deliberações da AG EN Powered by SlickText.com Hot this week News Room Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on... May 24, 2025 0 – Largest hypertension trial of an aldosterone synthase inhibitor... News Room ZLNA – Issuance of shares through set-off of option exercise fee May 24, 2025 0 Oslo, 24 May 2025: Zelluna ASA (the "Company") refers... News Room NEXTGEN DIGITAL CLOSES THIRD AND FINAL TRANCHE OF THE NON-BROKERED PRIVATE PLACEMENT OF SPECIAL WARRANTS AND COMMON SHARES May 24, 2025 0 Not for distribution to United States newswire services or... News Room BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain. May 24, 2025 0 Los Angeles, CA and Vancouver, BC, May 23,... News Room Pelican Acquisition Corporation Announces Pricing of $75,000,000 Initial Public Offering May 24, 2025 0 NEW YORK, May 23, 2025 (GLOBE NEWSWIRE)... Topics News Room Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on... 0 – Largest hypertension trial of an aldosterone synthase inhibitor... News Room ZLNA – Issuance of shares through set-off of option exercise fee 0 Oslo, 24 May 2025: Zelluna ASA (the "Company") refers... News Room NEXTGEN DIGITAL CLOSES THIRD AND FINAL TRANCHE OF THE NON-BROKERED PRIVATE PLACEMENT OF SPECIAL WARRANTS AND COMMON SHARES 0 Not for distribution to United States newswire services or... News Room BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain. 0 Los Angeles, CA and Vancouver, BC, May 23,... News Room Pelican Acquisition Corporation Announces Pricing of $75,000,000 Initial Public Offering 0 NEW YORK, May 23, 2025 (GLOBE NEWSWIRE)... News Room Silvercrest Asset Management Group Inc. Announces $25 Million Common Stock Repurchase Program 0 NEW YORK, May 23, 2025 (GLOBE NEWSWIRE)... News Room Boundless Bio Announces Portfolio Prioritization and Runway Extension 0 Portfolio prioritization focuses on novel-novel combination therapy of BBI-355... News Room Lake Shore Bancorp, Inc. Announces Commencement of Stock Offering 0 DUNKIRK, N.Y., May 23, 2025 (GLOBE NEWSWIRE)... Related Articles Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on... News Room May 24, 2025 ZLNA – Issuance of shares through set-off of option exercise fee News Room May 24, 2025 NEXTGEN DIGITAL CLOSES THIRD AND FINAL TRANCHE OF THE NON-BROKERED PRIVATE PLACEMENT OF SPECIAL WARRANTS AND COMMON SHARES News Room May 24, 2025 BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain. News Room May 24, 2025 Pelican Acquisition Corporation Announces Pricing of $75,000,000 Initial Public Offering News Room May 24, 2025 Popular Categories News RoomFeatured CompaniesVideos Previous articleAdagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual MeetingNext articleLegend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT